Clinical Practice Guidelines

HSCSN has adopted the following clinical practice guidelines, standards, and schedules to ensure the best and most current quality of care is provided to enrollees.

Asthma

• Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma (National Heart, Lung, & Blood Institute (NHLBI), 2007)
• 2020 Focused updates to the Asthma Guidelines (National Asthma Education and Prevention Program Coordinating Committee Expert Panel Workgroup, NHLBI, 2020)

Attention Deficit-Hyperactivity Disorder

• Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents (American Academy of Pediatrics, 2019)

Autism Spectrum Disorders

• Practice Parameter for the Assessment and Treatment of Children and Adolescents with Autism Spectrum Disorder (American Academy of Child and Adolescent Psychiatry, 2014)
• Identification, Evaluation, and Management of Children with Autism Spectrum Disorder (American Academy of Pediatrics, 2020)

Care Coordination/Care Management

• Care Management Standards of Practice (Case Management Society of America, 2016)
• National Care Coordination Standards for Children and Youth with Special Health Care Needs (National Academy for State Health Policy, 2020)

Cerebral Palsy

• Providing a Primary Care Medical Home for Children and Youth with Cerebral Palsy (American Academy of Pediatrics, 2022)

Congenital Heart Disease

• The Care of Children with Congenital Heart Disease in their Primary Medical Home (American Academy of Pediatrics, 2017)

Dental Care

• Periodicity of Examination, Preventive Dental Services, Anticipatory Guidance, and Oral Treatment for Infants, Children and Adolescents (American Academy of Pediatric Dentistry, 2022)
• Management of Dental Patients with Special Health Care Needs (American Academy of Pediatric Dentistry, 2021)

Diabetes

• Management of Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) in Children and Adolescents (American Academy of Pediatrics, 2013)
• Standards of Medical Care in Diabetes (American Diabetes Association, updated annually)

HIV 

• https://clinicalinfo.hiv.gov/en/guidelines>Federally Approved Clinical Practice Guidelines for HIV/AIDS (NIH)

Immunizations

• Recommended Child and Adolescent Immunization Schedule for ages 18 years or younger (Centers for Disease Control (CDC), 2023)

Influenza

• Recommendations for Prevention and Control of Influenza in Children 2023-2024 (American Academy of Pediatrics, 2024)

Mood Disorders

• Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents with Major and Persistent Depressive Disorders (American Academy of Child & Adolescent Psychiatry, 2023)
• Practice Guideline for the Treatment of Patients with Major Depressive Disorder (American Psychiatric Association, 2010)

Obesity

• Pediatric Obesity—Assessment, Treatment, and Prevention (European Society of Endocrinology & Pediatric Endocrine Society, 2017)
• Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents with Obesity (American Academy of Pediatrics, 2023)

Obstetrics/Reproductive Health

• Guidelines for Perinatal Care, 8th edition (AAP & ACOG, 2017)
• The Initial Reproductive Health Visit (American College of Obstetricians and Gynecologists, revised 2020)

Respiratory Syncytial Virus (RSV)

• Updated Guidance for Palivizumab Synagis® Prophylaxis among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection (American Academy of Pediatrics, 2014)
• Palivizumab Prophylaxis in Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection (AAP, 2023)
• Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices—United States (ACIP, 2023)

Sickle Cell Disease

• Health Supervision for Children and Adolescents with Sickle Cell Disease: Clinical Report (American Academy of Pediatrics, 2024)
• Evidence-Based Management of Sickle Cell Disease, Expert Panel Report (National Heart, Lung & Blood Institute, 2014)
• Guideline for Sickle Cell Disease: Prevention, Diagnosis, and Treatment of Cerebrovascular Disease in Children and Adults (American Society for Hematology, 2020)
• Guidelines for Sickle Cell Disease: Cardiopulmonary and Kidney Disease (American Society for Hematology, 2019)
• Guidelines for Sickle Cell Disease: Management of Acute and Chronic Pain (American Society of Hematology, 2020)
• Guidelines for Sickle Cell Disease: Transfusion Support (American Society of Hematology, 2020)

Spina Bifida

• Providing a Primary Care Medical Home for Children and Youth with Spina Bifida (American Academy of Pediatrics, 2011)

Substance Use Disorder

• Practice Parameter for the Assessment and Treatment of Children and Adolescents with Substance Use Disorders (American Academy of Child and Adolescent Psychiatry, 2005)
• The ASAM National Practice Guideline For the Treatment of Opioid Use Disorder 2020 Focused Update (American Society of Addiction Medicine, 2020)

Transition

• Supporting the Health Care Transition From Adolescence to Adulthood in the Medical Home (American Academy of Pediatrics, 2018)
• Considerations for Alternative Decision-Making When Transitioning to Adulthood for Youth with Intellectual and Developmental Disabilities (American Academy of Pediatrics, 2024)